InteliCare Holdings (ASX:ICR) Debt-to-EBITDA : -0.27 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is InteliCare Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

InteliCare Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.31 Mil. InteliCare Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. InteliCare Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was A$-1.14 Mil. InteliCare Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.27.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for InteliCare Holdings's Debt-to-EBITDA or its related term are showing as below:

ASX:ICR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.25 Med: -0.04 Max: -0.01
Current: -0.23

During the past 4 years, the highest Debt-to-EBITDA Ratio of InteliCare Holdings was -0.01. The lowest was -0.25. And the median was -0.04.

ASX:ICR's Debt-to-EBITDA is ranked worse than
100% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs ASX:ICR: -0.23

InteliCare Holdings Debt-to-EBITDA Historical Data

The historical data trend for InteliCare Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InteliCare Holdings Debt-to-EBITDA Chart

InteliCare Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Debt-to-EBITDA

-0.06

-0.02

-0.01

-0.25

InteliCare Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial				-0.01	-	-0.21	-0.49	-0.27

Competitive Comparison of InteliCare Holdings's Debt-to-EBITDA

For the Health Information Services subindustry, InteliCare Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InteliCare Holdings's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InteliCare Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where InteliCare Holdings's Debt-to-EBITDA falls into.

InteliCare Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

InteliCare Holdings's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.727	+	0)	/	-2.895
	=	-0.25

InteliCare Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.306	+	0)	/	-1.138
	=	-0.27

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

InteliCare Holdings (ASX:ICR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

InteliCare Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of InteliCare Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

InteliCare Holdings (ASX:ICR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InteliCare Holdings Ltd (ASX:ICR) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

299 Vincent Street, Level 1, Leederville, Perth, WA, AUS, 6007

Website

https://www.intelicare.com.au

InteliCare Holdings Ltd is an Australian firm engaged in healthcare solutions through hardware, software service packaging which supports aging or disabled persons. Its platform provides families and caregivers with a real-time view of the well-being of people in an independent living environment. Business software uses discreet sensors that are placed around the home, in doorways and on key appliances, designed to gather information on movement, activity levels, temperature and more, to relay information about behaviour such as sleeping patterns, social outings, meal preparation, any potential health issues etc. The product portfolio includes InteliCare Hub, Smart sensors, Downloadable Applications, and Optional Duress Pendants. Substantial revenue comes from hardware sales.

InteliCare Holdings (ASX:ICR) Headlines

No Headlines